PlainRecalls
FDA Drug Moderate Class II Terminated

Thyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For intramuscular injection only, Rx Only, Two vials per Carton, Carton contains 2 vials of Thyrogen, Dilute with Sterile Water for Injection, Storage: store at 2-8 C, Manufactured by: Genzyme Corporation, Northborough, MA 01532 USA, Marketing Authorization holder: Sanofi-Aventis, NDC 58468-0030-2.

Reported: March 9, 2016 Initiated: February 16, 2016 #D-0730-2016

Product Description

Thyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For intramuscular injection only, Rx Only, Two vials per Carton, Carton contains 2 vials of Thyrogen, Dilute with Sterile Water for Injection, Storage: store at 2-8 C, Manufactured by: Genzyme Corporation, Northborough, MA 01532 USA, Marketing Authorization holder: Sanofi-Aventis, NDC 58468-0030-2.

Reason for Recall

Presence of Particulate Matter: Glass particles found in the product after reconstitution.

Details

Recalling Firm
Genzyme Corporation
Units Affected
4669 Cartons
Distribution
Nationwide, Puerto Rico and Malaysia, Taiwan, Brazil, and Israel.
Location
Cambridge, MA

Frequently Asked Questions

What product was recalled?
Thyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For intramuscular injection only, Rx Only, Two vials per Carton, Carton contains 2 vials of Thyrogen, Dilute with Sterile Water for Injection, Storage: store at 2-8 C, Manufactured by: Genzyme Corporation, Northborough, MA 01532 USA, Marketing Authorization holder: Sanofi-Aventis, NDC 58468-0030-2.. Recalled by Genzyme Corporation. Units affected: 4669 Cartons.
Why was this product recalled?
Presence of Particulate Matter: Glass particles found in the product after reconstitution.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 9, 2016. Severity: Moderate. Recall number: D-0730-2016.